{Reference Type}: Case Reports
{Title}: Chloroprocaine 3% for anesthesia during cesarean section in a patient with dopa-responsive dystonia: A case report.
{Author}: Zhou J;Zhou W;Luo D;
{Journal}: Medicine (Baltimore)
{Volume}: 103
{Issue}: 27
{Year}: 2024 Jul 5
{Factor}: 1.817
{DOI}: 10.1097/MD.0000000000038795
{Abstract}: <B>BACKGROUND: </B>Dopa-responsive dystonia (DRD) is a rare autosomal dominant hereditary disorder with a prevalence of 0.5 per million population. The disease is characterized by onset of dystonia in childhood, progressive aggravation of the dystonia with diurnal fluctuation, and complete or near complete alleviation of symptoms with low-dose oral levodopa. The incidence of DRD is low, and only a few publications have described this disorder connected with anesthesia.<BR><B>METHODS: </B>We present a case involving a pregnant woman with DRD who continued levodopa/benserazide throughout the pregnancy. The perioperative anesthesia management was described. We used chloroprocaine 3% for epidural anesthesia during cesarean section.<BR><B>METHODS: </B>Dopa-responsive dystonia.<BR><B>METHODS: </B>Levodopa/benserazide.<BR><B>RESULTS: </B>In summary, levodopa/benserazide was continued throughout our patient's pregnancy with a good obstetric outcome, and chloroprocaine was safely used in epidural anesthesia without deterioration of her dystonic symptoms.<BR><B>CONCLUSIONS: </B>Chloroprocaine was safely used in epidural anesthesia without deterioration of her dystonic symptoms.